Publications by authors named "Jochem Wassing"

Claim this Profile
A
Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus: 5 years follow-up from the COMPARE II trial.
Valeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, Jochem Wassing, Martin van der Ent

Int J Cardiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
Valeria Paradies, Georgios J Vlachojannis, Kees-Jan Royaards, Jochem Wassing, Martin van der Ent

Am J Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
Valeria Paradies, Pieter C Smits, Georgios J Vachojannis, Kees-Jan Royaards, Jochem Wassing

Cardiovasc Revasc Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
Pieter C Smits, Georgios J Vlachojannis, Eugene Patrick McFadden, Kees-Jan Royaards, Jochem Wassing

JACC Cardiovasc Interv· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial.
Elvin Kedhi, Marc Gomes, Kaiyum Sheik Joesoef, Jochem Wassing, Dick Goedhart

EuroIntervention· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial).
Pieter C Smits, Elvin Kedhi, Kees-Jan Royaards, Kaiyum Sheik Joesoef, Jochem Wassing

J Am Coll Cardiol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
Elvin Kedhi, Kaiyum Sheik Joesoef, Eugene McFadden, Jochem Wassing, Carlos van Mieghem

Lancet· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis